Herpesvirus Saimiri-induced Proteins in Lytically Infected Cells. I. Time-ordered Synthesis

References

1. Bayliss G. J., Nonoyama M. 1978; Mechanisms of infection with Epstein-Barr virus. III. The synthesis of proteins in superinfected Raji cells. Virology 87:204–207
   [Google Scholar]
2. Bayliss G. J., Wolf H. 1981; The regulated expression of Epstein-Barr virus. III. Proteins specified by EBV during the lytic cycle. Journal of General Virology 56:105–118
   [Google Scholar]
3. Bayliss G. J., Wolf H. 1982; Effect of the analogue canavanine on the synthesis of Epstein-Barr virus-induced proteins in superinfected Raji cells. Journal of Virology 41:1109–1111
   [Google Scholar]
4. Calnek B. W., Adldinger H. K., Kohn D. E. 1970; Feather follicle epithelium. A source of enveloped and infectious cell-free herpesvirus from Marek’s disease. Avian Disease 14:219–233
   [Google Scholar]
5. Deinhardt F., Deinhardt J. 1979; Comparative aspects: oncogenic animal herpesviruses. In The EpsteinBarr Virus pp 374–415 Edited by Epstein M. A., Achong B. G. Berlin: Springer-Verlag;
   [Google Scholar]
6. Deinhardt F., Falk L. A., Wolfe L. G. 1974; Simian herpesviruses and neoplasia. Advances in Cancer Research 19:167–205
   [Google Scholar]
7. Feighny R. J., Henry B. E. II, Pagano J. S. 1981; Epstein-Barr virus polypeptides: effect of inhibition of viral DNA replication on their synthesis. Journal of Virology 37:61–71
   [Google Scholar]
8. Fenwick M. L., Walker M. J. 1978; Suppression of the synthesis of cellular macromolecules by herpes simplex virus. Journal of General Virology 41:37–51
   [Google Scholar]
9. Honess R. W., Roizman B. 1974; Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. Journal of Virology 14:8–19
   [Google Scholar]
10. Honess R. W., Roizman B. 1975; Regulation of herpesvirus macromolecular synthesis; sequential transition of polypeptide synthesis requires functional viral polypeptides. Proceedings of the National Academy of Sciences of the United States of America 72:1276–1295
    [Google Scholar]
11. Honess R. W., Watson D. H. 1977a; Unity and diversity in the herpesviruses. Journal of General Virology 37:15–37
    [Google Scholar]
12. Honess R. W., Watson D. H. 1977b; Herpes simplex virus resistance and sensitivity to phosphonoacetic acid. Journal of Virology 21:584–600
    [Google Scholar]
13. Hudewentz J., Bornkamm G. W., Zur Hausen H. 1980; Effect of the diterpene ester TPA on Epstein-Barr antigen- and DNA-synthesis in producer and nonproducer cell lines. Virology 100:175–178
    [Google Scholar]
14. Kallin B., Luka J., Klein G. 1979; Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells. Journal of Virology 32:710–716
    [Google Scholar]
15. Kawanishi M., Sugawara K., Ito Y. 1981; Epstein-Barr virus-induced polypeptides: a comparative study with superinfected Raji, IudR-treated and n-butyrate-treated P3HR1 cells. Virology 102:231–233
    [Google Scholar]
16. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
17. Lamon E. W., Lidin B. 1979; Differential expression of Epstein-Barr virus early antigens in cells containing different numbers of intrinsic viral genomes: DNA synthesis requirements. In Advances in Comparative leukemia Research pp 383–384 Edited by Yohn D. S., Lapin B. A., Blakeslee J. R. Amsterdam: Elsevier/North-Holland;
    [Google Scholar]
18. Luka J., Kallin B., Klein G. 1979; Introduction of Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94:228–232
    [Google Scholar]
19. Mele J., Glaser R., Nonoyama M., Zimmermann J., Rapp F. 1974; Observations on the resistance of Epstein-Barr virus DNA synthesis to hydroxyurea. Virology 62:102–111
    [Google Scholar]
20. Meléndez L. V., Daniel M. D., Hunt R. D., Garcia F. G. 1968; An apparently new herpesvirus from primary kidney cultures of the squirrel monkey (Saimiri sciureus). Laboratory Animal Care 18:374–381
    [Google Scholar]
21. Meléndez L. V., Hunt R. D., Daniel M. S., Garcia F. G., Fraser C. E. O. 1969; Herpesvirus Saimiri. II. Experimentally induced malignant lymphoma in primates. Laboratory Animal Care 19:378–386
    [Google Scholar]
22. Meléndez L. V., Hunt R. D., Daniel M. D., Blake J. B., Garcia F. G. 1971; Acute lymphocytic leukemia on owl monkeys inoculated with herpesvirus saimiri. Science 171:1161–1163
    [Google Scholar]
23. Morse L. S., Pereira L., Roizman B. A., Schaffer P. 1978; Anatomy of herpes simplex virus (HSV) DNA. X. mapping of viral genes by analysis of polypeptides and functions specified by HSV-1 x HSV-2 recombinants. Journal of Virology 26:389–410
    [Google Scholar]
24. Müller-Lantzsch N., Yamamoto N., Zur Hausen H. 1979; Analysis of early and late Epstein-Barr virus-associated polypeptides by immunoprecipitation. Virology 97:378–387
    [Google Scholar]
25. Rakusanova T., Ben-Porat T., Himeno M., Kaplan A. S. 1971; Early functions of the genome of herpesvirus. I. Characterization of the RNA synthesized in cycloheximide-treated infected cells. Virology 46:877–889
    [Google Scholar]
26. Wolf H., Bayliss G. J. 1979; The role of host-virus interaction for the development of herpesvirus induced malignancies of the New World primates. In Antiviral Mechanisms in the Control of Neoplasia pp 315–329 Edited by Chandra P. New York & London: Plenum Press;
    [Google Scholar]
27. Wolf H., Roizman B. 1978; The regulation of y (structural) polypeptide synthesis in herpes simplex virus types 1 and 2 infected cells. In Oncogenesis and Herpesviruses III, Part 1 pp 327–336 Edited by de The G., Henle W., Rapp F. Lyon: IARC Scientific Publications;
    [Google Scholar]
28. Wolf H., Bayliss G. J., Wilmes E. 1981; Biological properties of Epstein-Barr virus. In Cancer Campaign vol 5: pp 101–109 Edited by Grundmann E., Krueger G., Ablashi D. Stuttgart & New York: Gustav Fischer Verlag;
    [Google Scholar]
29. Yajima Y., Tanaka A., Nonoyama M. 1976; Inhibition of productive replication of Epstein-Barr virus by phosphonoacetic acid. Virology 71:353–354
    [Google Scholar]
30. Zur Hausen H., Hecker E., O’Neill F. J., Freese U. K. 1978; Persisting oncogenic herpesvirus induced by the tumour promoter TPA. Nature, London 272:373–375
    [Google Scholar]